Search

everythinglearnresearchcommunity

for

Search:↓

Hair loss can be caused by stress, aging, and harmful substances that create an imbalance in the body's natural processes.

Scalp cooling is the most effective FDA-approved method to prevent chemotherapy-induced hair loss, but more research is needed for other treatments.

No treatment fully prevents hair loss from chemotherapy yet.

Docetaxel often causes hair loss, with limited effective treatments and no cure for permanent hair loss.

Oncologists should better understand the unique impact of hair loss on Black breast cancer patients to offer more compassionate care.

Scalp cooling can prevent hair loss in 65% of chemotherapy patients, especially effective in breast cancer patients and certain chemotherapy types.

Wound healing can help prevent hair loss from chemotherapy in young rats by increasing interleukin-1β signaling.

Annurca apple extract may protect mouse hair from damage by chemotherapy and could help treat hair loss without promoting cancer growth.

Scalp cooling can help prevent chemotherapy-induced hair loss with a 50-90% success rate and is safe for patients.

Scalp cooling can prevent chemotherapy-induced hair loss, and certain treatments can speed up hair regrowth, but more research is needed for better treatments.

The document concludes that low-dose oral minoxidil successfully regrew hair in a patient with permanent hair loss after chemotherapy and stem cell transplant.

Cancer treatments often cause hair disorders, significantly affecting patients' quality of life, and better management methods are needed.

Chemotherapy can cause various skin reactions, with hair loss being the most common, and proper diagnosis and treatment of these reactions are important.

The formula YH0618 can reduce the harmful side effects of the chemotherapy drug Doxorubicin and protect healthy cells.

Some existing medicines show promise as safe treatments to protect against the side effects of radiation therapy.

Some breast cancer patients still experience hair loss three years after chemotherapy, especially with taxane-based treatments.

Permanent hair loss after bone marrow transplant can be caused by chemotherapy or chronic graft-versus-host disease.

Scalp cooling reduces chemotherapy-induced hair loss without increasing risk of skin metastases.

Light therapy can stimulate hair growth and is more effective when started early, but more research is needed on its long-term effects and optimal use.

Vitamin E in the diet might help protect against hair loss caused by the chemotherapy drug doxorubicin in rabbits.

Scalp cooling significantly reduces hair loss in chemotherapy patients.

Scalp cooling effectively prevents severe hair loss in breast cancer patients treated with docetaxel and is safe.

Chemotherapy often causes hair loss, nail changes, and mouth issues, but these are usually manageable.

Some breast cancer chemotherapy can cause permanent hair loss.

Pegylated liposomal doxorubicin is as effective as conventional doxorubicin but causes fewer heart problems and side effects.

Anti-cancer treatments can cause reversible hair loss, skin sensitivity, pigmentation changes, nail damage, and skin reactions, with a need for more research on managing these side effects.

Voriconazole can cause serious side effects, especially in long-term use.

CHOP chemotherapy causes many side effects but is generally well tolerated.

Chemotherapy can cause skin problems like hair loss, mouth sores, and skin darkening, and recognizing these can affect treatment decisions.

About half the patients treated with capecitabine and docetaxel developed severe hand-foot syndrome.